IL107454A - Pharmaceutical preparations containing imidazol-1-il compound - Google Patents

Pharmaceutical preparations containing imidazol-1-il compound

Info

Publication number: IL107454A
Authority: IL; Israel
Prior art keywords: compounds; imidazol; methyl; colon; acid addition
Prior art date: 1992-11-14

Application number

IL10745493A

Other languages

English (en)

Hebrew (he)

Other versions

IL107454A0 (en

Original Assignee

Solvay Pharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-11-14

Filing date

1993-11-01

Publication date

1999-12-22

1993-11-01 Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh

1994-02-27 Publication of IL107454A0 publication Critical patent/IL107454A0/xx

1999-12-22 Publication of IL107454A publication Critical patent/IL107454A/en

Links

239000008194 pharmaceutical composition Substances 0.000 title claims description 8
125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 title abstract 2
210000001072 colon Anatomy 0.000 claims abstract description 25
239000002253 acid Substances 0.000 claims abstract description 11
210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 8
150000003839 salts Chemical class 0.000 claims abstract description 7
230000008533 pain sensitivity Effects 0.000 claims abstract description 5
241000124008 Mammalia Species 0.000 claims abstract description 4
125000000217 alkyl group Chemical group 0.000 claims abstract description 4
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
239000001257 hydrogen Substances 0.000 claims abstract description 3
150000001875 compounds Chemical class 0.000 claims description 26
-1 imidazol-l-yl compounds Chemical class 0.000 claims description 17
238000002360 preparation method Methods 0.000 claims description 12
125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
241001465754 Metazoa Species 0.000 description 7
239000000203 mixture Substances 0.000 description 7
239000008187 granular material Substances 0.000 description 6
230000004899 motility Effects 0.000 description 6
239000003826 tablet Substances 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
239000002775 capsule Substances 0.000 description 5
210000003608 fece Anatomy 0.000 description 5
239000008101 lactose Substances 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
229920002261 Corn starch Polymers 0.000 description 4
235000019759 Maize starch Nutrition 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
239000003814 drug Substances 0.000 description 4
235000019359 magnesium stearate Nutrition 0.000 description 4
239000000463 material Substances 0.000 description 4
230000000144 pharmacologic effect Effects 0.000 description 4
229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
241000700159 Rattus Species 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000010339 dilation Effects 0.000 description 3
230000029142 excretion Effects 0.000 description 3
208000002551 irritable bowel syndrome Diseases 0.000 description 3
238000000034 method Methods 0.000 description 3
239000000546 pharmaceutical excipient Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000454 talc Substances 0.000 description 3
229910052623 talc Inorganic materials 0.000 description 3
229910002012 Aerosil® Inorganic materials 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
239000011651 chromium Substances 0.000 description 2
230000008602 contraction Effects 0.000 description 2
238000011835 investigation Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
239000001267 polyvinylpyrrolidone Substances 0.000 description 2
239000000843 powder Substances 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
PXLIDIMHPNPGMH-UHFFFAOYSA-N sodium chromate Chemical compound [Na+].[Na+].[O-][Cr]([O-])(=O)=O PXLIDIMHPNPGMH-UHFFFAOYSA-N 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000011477 surgical intervention Methods 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
208000009935 visceral pain Diseases 0.000 description 2
PGMSXNFJFNKUGN-RSAXXLAASA-N (12S)-12-[(2-methylimidazol-1-yl)methyl]-1-azatetracyclo[7.6.1.05,16.010,15]hexadeca-5(16),6,8,10(15)-tetraen-11-one hydrochloride Chemical compound Cl.CC1=NC=CN1C[C@H]1C(=O)C(C=2C=3N4CCCC=3C=CC=2)=C4CC1 PGMSXNFJFNKUGN-RSAXXLAASA-N 0.000 description 1
KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
208000018522 Gastrointestinal disease Diseases 0.000 description 1
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
241000700157 Rattus norvegicus Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000001949 anaesthesia Methods 0.000 description 1
150000008107 benzenesulfonic acids Chemical class 0.000 description 1
230000037396 body weight Effects 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
150000001991 dicarboxylic acids Chemical class 0.000 description 1
230000029087 digestion Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
201000006549 dyspepsia Diseases 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000002567 electromyography Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000008011 inorganic excipient Substances 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
229960003299 ketamine Drugs 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
239000003921 oil Substances 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000008012 organic excipient Substances 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
210000000664 rectum Anatomy 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000001117 sulphuric acid Substances 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
238000010998 test method Methods 0.000 description 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
230000009278 visceral effect Effects 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL10745493A 1992-11-14 1993-11-01 Pharmaceutical preparations containing imidazol-1-il compound IL107454A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4238553A DE4238553A1 (de)	1992-11-14	1992-11-14	Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number	Publication Date
IL107454A0 IL107454A0 (en)	1994-02-27
IL107454A true IL107454A (en)	1999-12-22

Family

ID=6472938

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL10745493A IL107454A (en)	1992-11-14	1993-11-01	Pharmaceutical preparations containing imidazol-1-il compound

Country Status (23)

Country	Link
US (1)	US5438068A (es)
EP (1)	EP0601345B1 (es)
JP (1)	JP3683286B2 (es)
KR (1)	KR100266715B1 (es)
CN (1)	CN1041053C (es)
AT (1)	ATE143597T1 (es)
AU (1)	AU667243B2 (es)
CA (3)	CA2504502A1 (es)
CZ (1)	CZ284154B6 (es)
DE (2)	DE4238553A1 (es)
DK (1)	DK0601345T3 (es)
DZ (1)	DZ1726A1 (es)
ES (1)	ES2092206T3 (es)
GR (1)	GR3021230T3 (es)
HU (1)	HU213506B (es)
IL (1)	IL107454A (es)
MX (1)	MX9307079A (es)
NO (1)	NO303926B1 (es)
NZ (1)	NZ250103A (es)
PH (1)	PH30702A (es)
RU (1)	RU2125877C1 (es)
SK (1)	SK278874B6 (es)
ZA (1)	ZA938463B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6365743B1 (en)	1995-10-13	2002-04-02	Duphar International Research B.V.	Process for the preparation of enantiomerically pure imidazolyl compounds
AU702594B2 (en) *	1995-10-13	1999-02-25	Duphar International Research B.V.	Process for the preparation of enantiomerically pure imidazolyl compounds
DE19813661A1 (de) *	1997-08-01	1999-02-04	Solvay Pharm Gmbh	Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
GB0216027D0 (en) *	2002-07-10	2002-08-21	Arachnova Therapeutics Ltd	New therapeutic use
US20040048874A1 (en) *	2001-05-22	2004-03-11	Bardsley Hazel Judith	New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
US7015333B2 (en) *	2002-11-18	2006-03-21	Solvay Pharmaceuticals B.V.	Process for preparation of imidazolyl compounds
EP1424337A1 (en) *	2002-11-26	2004-06-02	Solvay Pharmaceuticals GmbH	4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
MXPA05007381A (es) *	2003-01-13	2006-02-10	Dynogen Pharmaceuticals Inc	Metodo para el tratamiento de transtornos funcionales del intestino.
US7662831B2 (en)	2006-07-27	2010-02-16	Wyeth Llc	Tetracyclic indoles as potassium channel modulators
US7601856B2 (en)	2006-07-27	2009-10-13	Wyeth	Benzofurans as potassium ion channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE201165T1 (de) *	1985-03-14	1989-04-20	Beecham Group P.L.C., Brentford	Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome".
DE3885357T2 (de) *	1987-06-29	1994-03-24	Duphar Int Res	Anellierte Indolderivate.

1992
- 1992-11-14 DE DE4238553A patent/DE4238553A1/de not_active Withdrawn
1993
- 1993-10-29 NZ NZ250103A patent/NZ250103A/en not_active IP Right Cessation
- 1993-10-31 DZ DZ930117A patent/DZ1726A1/fr active
- 1993-11-01 IL IL10745493A patent/IL107454A/en not_active IP Right Cessation
- 1993-11-03 US US08/145,164 patent/US5438068A/en not_active Expired - Lifetime
- 1993-11-05 CZ CZ932365A patent/CZ284154B6/cs not_active IP Right Cessation
- 1993-11-05 SK SK1235-93A patent/SK278874B6/sk not_active IP Right Cessation
- 1993-11-08 KR KR1019930023616A patent/KR100266715B1/ko not_active Expired - Fee Related
- 1993-11-08 HU HU9303156A patent/HU213506B/hu not_active IP Right Cessation
- 1993-11-10 DE DE59304045T patent/DE59304045D1/de not_active Expired - Lifetime
- 1993-11-10 DK DK93118167.1T patent/DK0601345T3/da active
- 1993-11-10 EP EP93118167A patent/EP0601345B1/de not_active Expired - Lifetime
- 1993-11-10 ES ES93118167T patent/ES2092206T3/es not_active Expired - Lifetime
- 1993-11-10 AT AT93118167T patent/ATE143597T1/de active
- 1993-11-10 CN CN93114510A patent/CN1041053C/zh not_active Expired - Fee Related
- 1993-11-11 AU AU50643/93A patent/AU667243B2/en not_active Ceased
- 1993-11-11 JP JP28236093A patent/JP3683286B2/ja not_active Expired - Fee Related
- 1993-11-11 PH PH47242A patent/PH30702A/en unknown
- 1993-11-12 MX MX9307079A patent/MX9307079A/es not_active IP Right Cessation
- 1993-11-12 CA CA002504502A patent/CA2504502A1/en not_active Abandoned
- 1993-11-12 RU RU93052161A patent/RU2125877C1/ru not_active IP Right Cessation
- 1993-11-12 NO NO934090A patent/NO303926B1/no not_active IP Right Cessation
- 1993-11-12 CA CA002538177A patent/CA2538177A1/en not_active Abandoned
- 1993-11-12 CA CA002102960A patent/CA2102960C/en not_active Expired - Fee Related
- 1993-11-12 ZA ZA938463A patent/ZA938463B/xx unknown
1996
- 1996-10-03 GR GR960402404T patent/GR3021230T3/el unknown

Also Published As

Publication number	Publication date
DZ1726A1 (fr)	2002-02-17
CZ236593A3 (en)	1994-05-18
HU213506B (en)	1997-07-28
CN1092650A (zh)	1994-09-28
CZ284154B6 (cs)	1998-08-12
AU5064393A (en)	1994-05-26
NO934090D0 (no)	1993-11-12
ES2092206T3 (es)	1996-11-16
KR940010999A (ko)	1994-06-20
HK1006537A1 (en)	1999-03-05
DE59304045D1 (de)	1996-11-07
NO303926B1 (no)	1998-09-28
DK0601345T3 (da)	1996-11-18
AU667243B2 (en)	1996-03-14
HUT65978A (en)	1994-08-29
SK278874B6 (sk)	1998-04-08
CA2538177A1 (en)	1994-05-15
NO934090L (es)	1994-05-16
US5438068A (en)	1995-08-01
JP3683286B2 (ja)	2005-08-17
MX9307079A (es)	1994-05-31
SK123593A3 (en)	1994-09-07
ZA938463B (en)	1994-08-01
KR100266715B1 (ko)	2000-09-15
CA2102960C (en)	2005-08-02
EP0601345B1 (de)	1996-10-02
NZ250103A (en)	1997-06-24
RU2125877C1 (ru)	1999-02-10
JPH06211656A (ja)	1994-08-02
GR3021230T3 (en)	1997-01-31
CA2102960A1 (en)	1994-05-15
DE4238553A1 (de)	1994-05-19
CA2504502A1 (en)	1994-05-15
EP0601345A1 (de)	1994-06-15
PH30702A (en)	1997-09-16
ATE143597T1 (de)	1996-10-15
CN1041053C (zh)	1998-12-09
IL107454A0 (en)	1994-02-27

Legal Events

Date	Code	Title
2000-06-01	FF	Patent granted
2000-08-31	KB	Patent renewed
2004-01-04	KB	Patent renewed
2008-01-06	KB	Patent renewed
2012-10-31	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
AU2019202884B2 (en)	2021-03-04	Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
US5438068A (en)	1995-08-01	Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds
WO1996032948A1 (en)	1996-10-24	Method for treating dyskinesias
WO2014054880A1 (ko)	2014-04-10	신규한 폴리에틸렌글리콜과 비타민 씨를 함유하는 안정성이 개선된 장관 하제 조성물
KR100352898B1 (ko)	2002-12-26	새로운3-벤조일-3,7-디아자바이사이클로[3,3,1]노난-화합물을함유하는약제
JP2000264839A (ja)	2000-09-26	結腸領域で高まった疼痛感応性と関連する機能障害及び／又は下行腸管の疾患の治療及び／又は予防のための医薬調剤並びにその製造法
EP0831835B1 (en)	2002-10-30	Treating anorexia
EP1203582A1 (en)	2002-05-08	Medicinal compositions for treating lower uropathy
US6251896B1 (en)	2001-06-26	Compositions and methods for the management of Crohn's disease
CA1109796A (en)	1981-09-29	Process for the production of novel antidiarrheal agents
HK1006537B (en)	1999-03-05	Medicament containing an imidazol-1-yl compound
CN114786711A (zh)	2022-07-22	预防或治疗肠易激综合征的药物组合
CA2138957A1 (en)	1994-02-17	A remedy for inflammatory intestinal diseases
RU2121347C1 (ru)	1998-11-10	Лекарственный препарат
AU1284697A (en)	1997-10-01	Method for treating excessive aggression
EP0408108A2 (en)	1991-01-16	Pharmaceutical compositions containing acrylic acid derivatives and their use in the medicine
JPH0352855A (ja)	1991-03-07	アクリル酸塩、それらの製造方法、それらを含む薬剤組成物および医学におけるそれらの用途
JPH11222433A (ja)	1999-08-17	過敏性腸症候群の予防または治療薬
HU206616B (en)	1992-12-28	Process for producing pharmaceutical compositions containing pharmaceutically active tetrahydro-naphtalene derivative
JPH10218767A (ja)	1998-08-18	骨疾患治療剤